Mirtazapin Viatris (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine. It also antagonizes postsynaptic 5‑HT2 and 5‑HT3 serotonin receptors and H1 histamine receptors. This combined effect enhances serotonergic and noradrenergic neurotransmission while providing sedative and anxiolytic benefits.

The dosage of Mirtazapin Viatris is individualized by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. A healthcare professional will determine the appropriate starting dose and any subsequent adjustments, following local prescribing guidelines and patient-specific factors.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Mirtazapin Viatris. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Mirtazapin Viatris belongs to the NaSSA class, whereas many other antidepressants are selective serotonin reuptake inhibitors (SSRIs). Compared with SSRIs, mirtazapine often produces stronger sedation and appetite stimulation, which can be advantageous for patients with insomnia or weight loss, but may be less suitable for those who need to avoid sedation.

Mirtazapin Viatris should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Mirtazapin Viatris is taken orally, usually once daily in the evening to take advantage of its sedative effect. It may be swallowed whole with water and can be taken with or without food, depending on the prescriber’s instructions and patient tolerance.

Serious risks include the emergence of suicidal thoughts or behaviors, especially when therapy is initiated or doses are changed, severe allergic reactions such as rash or swelling, and rare blood disorders like agranulocytosis. Patients should seek immediate medical attention if they notice any of these symptoms.

Mirtazapin Viatris should be avoided in individuals with known hypersensitivity to mirtazapine or any of its excipients, and it is contraindicated in patients currently receiving monoamine oxidase inhibitors (MAOIs) or who have taken an MAOI within the past 14 days. Caution is also advised for patients with severe hepatic impairment.